ISOPTO CETAMIDE Drug Patent Profile
Which patents cover Isopto Cetamide, and when can generic versions of Isopto Cetamide launch?
Isopto Cetamide is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in ISOPTO CETAMIDE is sulfacetamide sodium. There is one drug master file entry for this compound. Nine suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isopto Cetamide
A generic version of ISOPTO CETAMIDE was approved as sulfacetamide sodium by CHARTWELL RX on October 18th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ISOPTO CETAMIDE?
- What are the global sales for ISOPTO CETAMIDE?
- What is Average Wholesale Price for ISOPTO CETAMIDE?
Summary for ISOPTO CETAMIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 1,133 |
| DailyMed Link: | ISOPTO CETAMIDE at DailyMed |
US Patents and Regulatory Information for ISOPTO CETAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | ISOPTO CETAMIDE | sulfacetamide sodium | SOLUTION/DROPS;OPHTHALMIC | 080020-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
